Smoking Cessation News and Research

RSS

Managing smoking cessation via a healthcare system model seems better than telephone quitline

A healthcare system model that offered tobacco cessation treatment to smokers being discharged from a hospital produced a higher rate of tobacco abstinence during the three- month program than referral to a state-based telephone quitline.

28 Jun 2022

Vitamins are a waste of money for non-pregnant and healthy Americans, scientists say

Drawn to the allure of multivitamins and dietary supplements filling nutritional gaps in their diet, people in the U.S. in 2021 spent close to $50 billion on vitamins and dietary supplements.

21 Jun 2022

Area-level education and income linked with patients' lung cancer stage at the time of diagnosis

Lung cancer is the leading cause of cancer-related deaths in the United States, and early detection and treatment are key to prolonging survival in patients.

20 Jun 2022

Varenicline improves quit rates among African American daily smokers

African Americans have been underrepresented in tobacco treatment research, including the clinical trials that led to the 2006 FDA approval of varenicline, the leading pharmacological treatment for smoking cessation commonly known by the brand name Chantix.

14 Jun 2022

$Study: Male smokers are at increased risk of osteoporosis, bone fractures, and early death$

Study: Male smokers are at increased risk of osteoporosis, bone fractures, and early death

It's no secret that puffing cigarettes is the culprit behind a whole host of ailments, including respiratory diseases and cancers of the lungs and throat.

8 Jun 2022

Banning menthol cigarettes likely to benefit public health and may lead to social justice and equity

As the Food and Drug Administration goes forward with its proposal to ban menthol cigarettes, Rutgers researchers insist the move is a step toward social justice and better health equity in the Black community, where menthol cigarettes have been heavily marketed by tobacco companies.

6 Jun 2022

Use of RAAS inhibitors reduced aneurysm rupture risk by 18%, finds study

A multi-center study of more than 3,000 people with high blood pressure and brain aneurysms found that the use of RAAS inhibitors, a class of blood pressure lowering medications, reduced the risk of an aneurysm rupture by 18%, according to new research published today in Hypertension, a peer-reviewed journal of the American Heart Association.

3 Jun 2022

UH experts in cloning and stem cell science take the first step toward unraveling cystic fibrosis

Two nationally recognized experts in cloning and stem cell science from the University of Houston are taking the first step toward limiting the consequences of chronic inflammation in cystic fibrosis (CF) by identifying the source of this persistent and enigmatic inflammation in CF lungs.

24 May 2022

Tribal pharmacy dispenses free meds and fills gaps for Native Americans in the city

Tucked away on a side street near downtown, the Mashkiki Waakaa'igan Pharmacy offers its Native American clientele the services of any ordinary drugstore — it dispenses critical medication and provides consultation on treatments.

24 May 2022

Study shows effectiveness of point-of-care smoking cessation program for cancer patients

New research in the May 2022 issue of JNCCN - Journal of the National Comprehensive Cancer Network finds the inclusion of the smoking cessation tool Electronic Health Record-Enabled Evidence-Based Smoking Cessation Treatment (ELEVATE, from Epic) into electronic health records (EHRs) can increase self-reported patient quit rates by more than 5 percentage points.

11 May 2022

New smoking-cessation program helps more cancer patients to quit successfully

Researchers at Siteman Cancer Center at Barnes-Jewish Hospital and Washington University School of Medicine in St. Louis have found a way to help more patients who want to stop smoking.

11 May 2022

Personalized text messaging program improves healthy lifestyle measures in heart attack survivors

A text messaging program successfully supported, informed and motivated people after a heart attack on how to prevent a second heart attack, according to new research published today in the American Heart Association's flagship, peer-reviewed journal Circulation.

9 May 2022

Combined use of traditional cigarettes and e-cigarettes does not reduce cardiovascular disease risk

People who use both traditional (combustible) cigarettes and e-cigarettes do not reduce their risk of cardiovascular disease compared to people who exclusively use traditional cigarettes, according to new research published today in the American Heart Association's flagship, peer-reviewed journal Circulation.

6 May 2022

Analysis finds reductions in cigarette use among people with major depression, substance use disorder

Significant reductions in cigarette use were found among U.S. adults with major depression, substance use disorder, or both from 2006 to 2019, according to a new analysis of nationally representative survey data published today in JAMA.

26 Apr 2022

Tobacco use increased in smokers trying to quit during COVID-19, study finds

While smoking rates have declined dramatically in the United States, there are still 35 million smokers. There are few data about whether, and if so, how current cigarette smoking habits among those trying to quit are affected by the COVID-19 pandemic.

11 Apr 2022

New research provides a scientific framework to allow the use of psilocybin for therapeutic reasons

A new paper by an Oregon State University-led research team provides a scientific framework to help shape the rollout of a program in Oregon that will legally permit the use of psilocybin for therapeutic reasons.

11 Apr 2022

City of Hope's late-breaking clinical trial data to be presented at AACR

Researchers at City of Hope, one of the largest cancer research and treatment organizations in the United States, will present late-breaking and clinical trial findings at this year's American Association for Cancer Research Annual Meeting, which begins today.

8 Apr 2022

Smoking cessation could help heart disease patients gain five years of healthy life

Smoking cessation adds the same number of heart disease-free years to life as three preventive medications combined, according to research presented at ESC Preventive Cardiology 2022, a scientific congress of the European Society of Cardiology.

7 Apr 2022

Genetic risk score predicts the likelihood of cardiovascular events in people with Type 2 diabetes

A risk score based on a gene map predicted the likelihood of high blood pressure leading to heart problems or stroke in people with Type 2 diabetes, according to a study published today in the American Heart Association's peer-reviewed journal Hypertension.

4 Apr 2022

Combination treatment could benefit smokers who also drink heavily

One in five people who smoke also drink heavily, but they show worse outcomes than non-heavy drinkers in quitting smoking and are often excluded from smoking cessation trials.

4 Mar 2022